Medtronic Achieves Three Milestones for the MiniMed 780G System within the US
Medtronic has reported three milestones within the US, increasing entry to its MiniMed 780G insulin supply system for people with kind 1 diabetes (T1D) and insulin-dependent kind 2 diabetes (T2D).
These embody the U.S. Meals and Drug Administration (FDA) approval to make use of the MiniMed 780G System with ultra-rapid-acting insulins, in addition to the approval of the system with Intuition for insulin-requiring T2D.
Uncover B2B advertising and marketing that delivers
Mix enterprise intelligence and editorial excellence to achieve engaged professionals throughout 36 main media platforms.
Extra info
The corporate additionally introduced Medicare entry to the MiniMed 780G system together with Abbott’s Intuition sensor.
Medicare and Medicare Benefit beneficiaries can now get hold of the system together with the Intuition sensor, which is compact and modern, will be worn discreetly and permits for as much as 15 days of steady use.
This expands the selection past Simplera Sync and Guardian 4 sensors for Medicare customers. Medtronic Diabetes works with distributor companions to offer quick transport and help for eligible clients.
The FDA authorised the usage of the ultra-rapid-acting insulins Fiasp and Lyumjev with the MiniMed 780G System, offering improved flexibility and remedy personalization for individuals with T1D or T2D who require insulin.
As well as, the MiniMed 780G pump was authorised instead controller (ACE) gadget for insulin-requiring T2D and the SmartGuard algorithm as an interoperable automated glycemic controller (iAGC). This enables integration with Abbott’s Intuition sensor.
The expanded approvals imply people can now order the MiniMed 780G system with Intuition, Guardian 4 or Simplera Sync sensors for broader personalization in diabetes administration.
mentioned Que Dallara, govt vice chairman and president of Medtronic. “These milestones replicate our continued dedication to increasing entry and giving individuals with diabetes extra alternative in how they handle their situation.
“By increasing the sensor and insulin choices for the MiniMed 780G system, we’re enabling extra individuals to profit from automated insulin supply that helps less complicated meals, better flexibility and extra assured diabetes administration, making on a regular basis life a lot simpler.”
In January 2026, Medtronic obtained 510(ok) clearance from the FDA for its MiniMed Go Sensible MDI System, an answer geared toward supporting people with insulin-dependent T1D and T2D.
